Delivery Order SPE2DB24D6041-SPE2DB25FKCJC
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for Annovera vaginal rings, with a ceiling value of $6,710.26. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $2,570.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,234.04 to AmerisourceBergen Drug Corp for Annovera vaginal rings, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order, indicating it flows from a larger indefinite delivery contract vehicle. The contraceptive product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,637.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 25, 2025, with completion expected by July 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.98 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,554.70 to AmerisourceBergen Drug Corp for Annovera vaginal rings, with an ultimate completion date of August 21, 2025. This is a firm fixed-price, non-set-aside contract issued on August 20, 2025, to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop...
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,014.46 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Annovera vaginal rings. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award carries no set-aside designation and will...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,976.98 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of Annovera vaginal rings. This contract has an ultimate completion date of August 19, 2024 and does not utilize a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for the provision...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the ANNOVERA vaginal ring product. The $4,387.52 firm-fixed-price contract has an ultimate completion date of August 8, 2024. This order is under a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,304.84, is for the supply of the vaginal contraceptive ring product Annovera. The contract is a firm-fixed-price delivery order with a performance period through May 13, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCJCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,754.04 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This contract, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this contract demonstrates AmerisourceBergen's continued role as a critical pharmaceutical supplier within the federal medical supply chain. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio reflects its established capability to meet Defense Logistics Agency requirements for specialized pharmaceutical products across multiple therapeutic domains, serving the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 7/24/25 |